These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15273309)

  • 1. Detecting hidden sequence propensity for amyloid fibril formation.
    Yoon S; Welsh WJ
    Protein Sci; 2004 Aug; 13(8):2149-60. PubMed ID: 15273309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid assessment of contact-dependent secondary structure propensity: relevance to amyloidogenic sequences.
    Yoon S; Welsh WJ
    Proteins; 2005 Jul; 60(1):110-7. PubMed ID: 15849755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
    Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
    J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intact human acetylcholinesterase C-terminal oligomerization domain is alpha-helical in situ and in isolation, but a shorter fragment forms beta-sheet-rich amyloid fibrils and protofibrillar oligomers.
    Cottingham MG; Voskuil JL; Vaux DJ
    Biochemistry; 2003 Sep; 42(36):10863-73. PubMed ID: 12962511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of discordant helices in amyloid fibril-forming proteins.
    Päiviö A; Nordling E; Kallberg Y; Thyberg J; Johansson J
    Protein Sci; 2004 May; 13(5):1251-9. PubMed ID: 15096631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
    Li HT; Du HN; Tang L; Hu J; Hu HY
    Biopolymers; 2002 Aug; 64(4):221-6. PubMed ID: 12115139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases.
    Pawar AP; Dubay KF; Zurdo J; Chiti F; Vendruscolo M; Dobson CM
    J Mol Biol; 2005 Jul; 350(2):379-92. PubMed ID: 15925383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A β-hairpin-binding protein for three different disease-related amyloidogenic proteins.
    Shaykhalishahi H; Mirecka EA; Gauhar A; Grüning CS; Willbold D; Härd T; Stoldt M; Hoyer W
    Chembiochem; 2015 Feb; 16(3):411-4. PubMed ID: 25557164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
    Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
    J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties.
    Tenidis K; Waldner M; Bernhagen J; Fischle W; Bergmann M; Weber M; Merkle ML; Voelter W; Brunner H; Kapurniotu A
    J Mol Biol; 2000 Jan; 295(4):1055-71. PubMed ID: 10656810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus prediction of amyloidogenic determinants in amyloid fibril-forming proteins.
    Hamodrakas SJ; Liappa C; Iconomidou VA
    Int J Biol Macromol; 2007 Aug; 41(3):295-300. PubMed ID: 17477968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro preparation of prefibrillar intermediates of amyloid-beta and alpha-synuclein.
    Lashuel HA; Grillo-Bosch D
    Methods Mol Biol; 2005; 299():19-33. PubMed ID: 15980593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
    Kapurniotu A; Schmauder A; Tenidis K
    J Mol Biol; 2002 Jan; 315(3):339-50. PubMed ID: 11786016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease.
    Li J; Zhu M; Manning-Bog AB; Di Monte DA; Fink AL
    FASEB J; 2004 Jun; 18(9):962-4. PubMed ID: 15059976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-synuclein exhibits chaperone activity more efficiently than alpha-synuclein.
    Lee D; Paik SR; Choi KY
    FEBS Lett; 2004 Oct; 576(1-2):256-60. PubMed ID: 15474047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
    El-Agnaf OM; Paleologou KE; Greer B; Abogrein AM; King JE; Salem SA; Fullwood NJ; Benson FE; Hewitt R; Ford KJ; Martin FL; Harriott P; Cookson MR; Allsop D
    FASEB J; 2004 Aug; 18(11):1315-7. PubMed ID: 15180968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Template induced conformational change of amyloid-β monomer.
    Xi W; Li W; Wang W
    J Phys Chem B; 2012 Jun; 116(25):7398-405. PubMed ID: 22670893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: implications for fibrillation.
    Marsh JA; Singh VK; Jia Z; Forman-Kay JD
    Protein Sci; 2006 Dec; 15(12):2795-804. PubMed ID: 17088319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of introducing a short amyloidogenic sequence from the Aβ peptide at the N-terminus of 18-residue amphipathic helical peptides.
    SivakamaSundari C; Rukmani S; Nagaraj R
    J Pept Sci; 2012 Feb; 18(2):122-8. PubMed ID: 22052825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.